3D MEDICINES Appoints Xia Fang as Authorized Representative

Stock News
Jun 30

3D MEDICINES (HKEX: 01244) has announced a change in its corporate secretariat. The Hong Kong Stock Exchange has confirmed that the company's current Co-Company Secretary, Xia Fang, meets the qualifications required under Rules 3.28 and 8.17 of the Listing Rules to act as the company's Company Secretary.

Consequently, Li Jingyi has resigned from her positions as Co-Company Secretary and as the company's Authorized Representative under Rule 3.05 of the Listing Rules, effective from June 30, 2026.

Following Ms. Li's resignation, Ms. Xia will continue to serve as the company's sole Company Secretary. The board of directors further announced that Ms. Xia has been appointed as the Authorized Representative, with the appointment also taking effect from June 30, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10